Antares Pharma Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$776.75 | $636.99 | 12.97% | 9 | $699.39B |
| ABBV | AbbVie | Outperform |
9
|
$161.72 | $178.42 | 15.01% | 11 | $286.35B |
| PFE | Pfizer | Outperform |
2
|
$27.18 | $32.87 | 12.21% | 6 | $153.91B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.21 | $58.15 | 22.14% | 10 | $89.62B |
| CVS | CVS Health | Outperform |
12
|
$56.31 | $89.54 | 47.40% | 4 | $70.98B |
| GSK | GSK | Outperform |
12
|
£17.05 | £17.30 | 14.37% | 12 | £69.53B |
| SUNPHARMA | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.50k | Rp1.52k | 5.52% | 25 | Rp3.60T |
| WST | West Pharmaceutical Services | Outperform |
18
|
$363.43 | $380.80 | 7.31% | 2 | $26.47B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.83B |
| VTRS | Viatris Inc | Hold |
8
|
$11.63 | $11.73 | 3.18% | 5 | $13.74B |
| 4183 | Mitsui Chemicals | Outperform |
18
|
¥3.99k | ¥4.62k | 27.98% | 0 | ¥837.19B |
| YPSN | Ypsomed Holding | Outperform |
18
|
CHF329.00 | CHF330.00 | 0.30% | 1 | CHF4.49B |
| PRGO | Perrigo Co PLC | Buy |
16
|
$32.90 | $44.75 | 20.36% | 0 | $4.43B |
| ALCJ | Crossject Société Anonyme | Buy |
9
|
2.05€ | 7.10€ | 143.90% | 0 | 78.33€M |
| MDP | Medexus Pharmaceuticals | Outperform |
0
|
C$1.75 | C$4.08 | 71.43% | 1 | C$45.49M |